Drug profile · INN
moroctocog alfa
REFACTO AF
moroctocog alfa (REFACTO AF) is a coagulation factor viii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — moroctocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
moroctocog alfa (REFACTO AF) is a coagulation factor viii exogenous protein.
Key facts
INN moroctocog alfa
Brand REFACTO AF
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is moroctocog alfa?
moroctocog alfa (REFACTO AF) is a coagulation factor viii exogenous protein.
What is the brand name for moroctocog alfa?
REFACTO AF is a marketed brand name for moroctocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.